Mindray stock: At CNY 167.55, Mindray stock sits 26.45 percent below its 52-week high
Published on 10/19/2026 at 16:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice position and valuation
- On October 19, 2026, Mindray sat 26.45 percent below its 52-week high.
- Mindray's P/E was 25.82.
- Mindray stock was at CNY 167.55 at 3:04 p.m. CST on October 19, 2026, up 0.15 percent versus the prior Shenzhen close.
- Mindray is scheduled to report third-quarter 2026 results on October 30, 2026.
Mindray (ISIN CNE100003G67) stood at CNY 167.55 on Shenzhen at 3:04 p.m. CST on October 19, 2026, 26.45 percent below its 52-week high. The stock's modest 0.15 percent daily gain leaves the broader price picture largely unchanged.
Mindray trades on the Shenzhen Stock Exchange under ticker 300760, and Chozan describes the company as a global supplier of medical devices and healthcare solutions through its Chozan company profile. Its products cover patient monitoring, life support, in-vitro diagnostics and medical imaging.
Price stays below yearly high
The 52-week range was CNY 130.66 to CNY 227.81 as of October 19, 2026. The current level was 28.24 percent above the low and 26.45 percent below the high, placing the stock well inside its annual band rather than at an extreme. Trading volume reached 8,916,149 shares, compared with an average of 8,861,744 shares.
Valuation and next results
Mindray's market capitalization was CNY 203.0 billion and its P/E was 25.82 on October 19, 2026. The next scheduled reporting date is October 30, 2026, when the company is expected to publish third-quarter 2026 results, according to Simply Wall St. That date gives the valuation a clear near-term calendar marker.
On September 30, 2026, Citic Securities described Mindray's domestic recovery and overseas expansion as a longer-cycle improvement in a report carried by Futunn. The report also identified foreign-exchange effects and healthcare procurement policies as factors that could influence margins.
Comparison with peers
Mindray: plus 0.15 percent, P/E 25.82, market capitalization CNY 203.0 billion
Lepu Medical (Shenzhen Stock Exchange, CNY): plus 0.80 percent, P/E 27.06, market capitalization CNY 20.9 billion
Daan Gene (Shenzhen Stock Exchange, CNY): minus 2.70 percent, market capitalization CNY 7.6 billion
Stock price and next session
Mindray's current price sits closer to the middle of its annual range than to either boundary, while the October 30 reporting date is the next concrete event for the shares. The market capitalization and P/E place the company in a large-cap medical-device comparison set, but the peer session moves were mixed.
Mindray market data
- Company: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- ISIN: CNE100003G67
- Ticker: 300760
- Primary exchange: Shenzhen Stock Exchange
- Price Shenzhen Stock Exchange (as of October 19, 2026, 3:04 p.m. CST): CNY 167.55
- Change versus prior Shenzhen close of October 16, 2026: plus 0.15 percent
- 52-week range: CNY 130.66-CNY 227.81 (as of October 19, 2026)
- Market capitalization: CNY 203.0 billion (as of October 19, 2026)
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report Shanghai Composite.
